H.C. Wainwright Keeps Their Buy Rating on Actinium Pharmaceuticals (ATNM)

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), wit...